Skip to main content

Find Clinical Trials

Clinical trial condition

HCC

Explore clinical trials studying HCC. Study availability and eligibility vary by location and protocol.

98 public trials 29 recruiting studies

Refine in advanced search Browse all conditions

HCC trial results

Not yet recruiting

Efficacy and Safety of Neoadjuvant Therapy in Patients With Resectable HCC Screened by a Multimodal Deep Learning Model.

NCT06311916

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +13 more
Locations: Not specified

View Trial Details

Not yet recruiting

SALT for Liver Cirrhosis With HCC

NCT06069947

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +13 more
Locations: Not specified

View Trial Details

Not yet recruiting

Predictive Value of HBV pgRNA on Long-term Outcomes in Hepatitis B Patients Treated With Antiviral Therapy

NCT05965388

Conditions: HBV, HCC
Locations: The First Affiliated Hospital of Anhui Medical University Hefei, Anhui, China

The First Affiliated Hospital of Fujian Medical University Fuzhou, Fujian, China

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology Wuhan, Hubei, China

Jiangsu Province Hospital Nanjing, Jiangsu, China

View Trial Details

Not yet recruiting

Study of Long Non-coding RNA SNHG15 as a Novel Biomarker in HBV Associated HCC

NCT05840133

Conditions: HCC
Locations: Not specified

View Trial Details

Active, not recruiting

TACE and SBRT Followed by Double Immunotherapy for Downstaging Hepatocellular Carcinoma

NCT04988945

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: Department of Surgery, The University of Hong Kong Hong Kong

The University of Hong Kong Hong Kong

View Trial Details

Active, not recruiting

GNOS-PV02 Personalized Neoantigen Vaccine, INO-9012 and Pembrolizumab in Subjects With Advanced HCC

NCT04251117

Conditions: HCC
Locations: Johns Hopkins Hospital Baltimore, Maryland, United States

Icahn School of Medicine at Mount Sinai New York, United States

Auckland Clinical Studies Auckland, New Zealand

View Trial Details

Active, not recruiting

Optimizing Y90 Therapy for Radiation Lobectomy

NCT04390724

Conditions: Adenocarcinoma, Adult Primary Liver Cancer, Carcinoma, +17 more
Locations: Mayo Clinic Jacksonville, Florida, United States

Northwestern University Chicago, Illinois, United States

View Trial Details

Active, not recruiting

Accumulation of Lipid Droplets as an Underlying Cause of the Progression of Fatty Liver Disease to Liver Cancer

NCT07775716

Conditions: HCC, MASLD
Locations: Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico - Istituto di Ricovero e Cura a Carattere Scientifico di natura pubblica Milan, Milano, Italy

View Trial Details

Active, not recruiting

A Study to Evaluate the Safety, Pharmacokinetics, and Activity of Enzelkitug as a Single Agent and in Combination With Checkpoint Inhibitor in Participants With Locally Advanced or Metastatic Solid Tumors

NCT05581004

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +57 more
Locations: Stanford University San Francisco, California, United States

University Of Colorado Aurora, Colorado, United States

Florida Cancer Specialists - Sarasota Sarasota, Florida, United States

Winship Cancer Institute Atlanta, Georgia, United States

View all 36 locations

View Trial Details

Active, not recruiting

Durvalumab and Tremelimumab in Combination With Y-90 SIRT for Intermediate Stage HCC

NCT04522544

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +10 more
Locations: Universitätsklinikum Bonn Bonn, Germany

Universitätsklinikum Köln Cologne, Germany

Universitätsklinikum Essen Essen, Germany

Universitätsmedizin Göttingen Göttingen, Germany

View Trial Details